Why buy this course?

The course you are looking at is not like any other e-Learning course you have ever taken. Watch this short video to learn why!

Medicare GUARD Model: International Benchmarking for Part D Drug Rebates

$199.99

Learn how the GUARD Model proposed rule introduces a groundbreaking approach to controlling Medicare Part D prescription drug costs. This course unpacks the structure and anticipated effects of using international price benchmarks to calculate inflation rebates for certain high-cost drugs and biologics. Gain actionable insights on drug selection criteria, manufacturer requirements, public comment opportunities, beneficiary protections, and the rule’s potential to lower costs without sacrificing care quality.

In this course you will learn the following:
* Explain the purpose and goals of the GUARD Model.
* Describe the context of rising drug costs and Medicare Part D.
* Identify opportunities for public participation and comment.
* Recognize that the rule is proposed and subject to change.
* Outline the structure and major provisions of the GUARD Model.

NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year.  At the end of the one year term, the course will be set to “inactive”. 

Why This Course is Important
Without this course, learners risk missing crucial updates on Medicare’s evolving drug pricing models, the mechanics of alternative rebate calculations, and how international benchmarks could impact beneficiaries, manufacturers, and health plans.

Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model.

Key regulatory references include:

  • 42 CFR Part 514

Course SKU
FR-25-1649-1